Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
Looks like a steady rise here, perhaps another bid? Anyway SPI are going to be very busy for the next 5 years with the state of the NHS. The largest play on the private healthcare market in the UK.
I’m invested here and pleased with the imminent approval of Chronocort. As a medic, I know physicians will use this off label for treatment of Addison’s disease and other conditions where steroids are prescribed long term. This will be a huge market compared to CAH. It happens all the time with new drugs. The revenues will be correspondingly increased.
Steady rise over the last couple of weeks with high volumes. Is there some stakebuilding?
Any views?
I'm invested here and I think OPTI is very undervalued.
It has circa 30% stake in SKIN which currently has mcap of 55m and is on the up.
As stated revenues coming in and hitting bottom line. It will just take some proper marketing by one of the many partners/distributors and sales will balloon. We live in a very connected world and many folk are looking for natural ways of solving health problems.
The human microbiome is a very active area of medical research and OPTI have patented products and a huge research base which in itself is worth a lot.
All my opinion no advice intended.
I'm in the medical profession and everyday I'm talking to patients who want to know when they can get their procedure done. As expected there is a large waiting list due to CV-19 and this is going to take several years to get back to 'normal' or acceptable levels again.
Patients are asking to go private more than I have witnessed ever before in my 30 year carer. The private sector is not fully up and running but when is there will be huge volumes of work to get through. I can't see the NHS managing without handing contracts to the private providers and in parallel many folk with pay rather than wait.
All this bodes well for Spire and I would not be surprised if it doesn't get taken out at this price.
Having watched to webcast I think they have stumbled upon something that will have a very good chance of approval. There is nothing to be lost for patients who need help for ED. It has near zero side effects and no known interactions with other medications. I work in the medical field and I can see a gap in the market that this could fill. Thus I'm now invested.
I've not bothered to contact Mannion-waste of time!
I agree with others that the weak pound is going to make UK PLC look very cheap. There is going to be unmet demand in NHS and it's only a matter of time before this spills into private sector. It's cyclical due to ups and downs of NHS funding depending on how the political wind is blowing. At the moment money is flowing back in and so good news for SPI.
When they had their first profit warning dropping to 190p I had a long chat to Mr M and sent him a detailed email on areas the company could improve on.
Gave me some lip service and I never heard back.
I'm in the medical profession and there is an acute capacity shortage in the NHS to get routine ops done and there is lots of capacity in the private sector.
They just need to get their act together-but as already stated SPI will be taken over soon IMHO.
Just look at recent RNSs.
Norges Bank increased their holding from 4.16% to 5.04%
Highclere investors declared a new interest of 5.03%
Both before results came out.
I think there is some tree shaking and general drift down by MMs but when a whiff of a takeover comes about this will shoot up as not much free float about.